FindTrial
Sign In

Recaticimab

DRUG4 trials

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Second Affiliated Hospital of Nanchang University, Peking Union Medical College Hospital, Hunan Cancer Hospital

Conditions

ALK Fusion-positive Non-small Cell Lung CancerCognitive ImpairmentIntracranial ArteriosclerosisNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)STEMI - ST Elevation Myocardial InfarctionSymptomatic Intracranial Atherosclerotic Stenosis

Phase 3

PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis
Not yet recruitingNCT07119918
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySymptomatic Intracranial Atherosclerotic Stenosis
Start: 2025-09-01End: 2029-12-01Target: 5276Updated: 2025-08-13

Phase 4

Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Not yet recruitingNCT07290699
Second Affiliated Hospital of Nanchang UniversityNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), STEMI - ST Elevation Myocardial Infarction
Start: 2026-01-01End: 2028-08-30Target: 2442Updated: 2025-12-18
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial
Not yet recruitingNCT07605130
Peking Union Medical College HospitalCognitive Impairment, Intracranial Arteriosclerosis
Start: 2026-09-17End: 2029-07-31Target: 440Updated: 2026-09-15
Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed
Not yet recruitingNCT07674368
Hunan Cancer HospitalALK Fusion-positive Non-small Cell Lung Cancer
Start: 2026-07-10End: 2028-08-01Target: 29Updated: 2026-07-01